Shinichiro Inoue
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Shinichiro Inoue has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
Hideyuki Kosumi
Department of Dermatology, Faculty of Medicine and Graduate School of Medicine Hokkaido University Sapporo Japan
1 shared publication- Hideyuki Ujiie
Department of Dermatology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University
1 shared publication Hitoshi Tanimukai
Graduate School of Nursing, Nagoya City University, Mizuho-Ku, Nagoya, 467-8601, Japan
1 shared publication- Inkin Ujiie
Department of Dermatology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan
1 shared publication - Joohyung Youh
Department of Dermatology JR Sapporo Hospital Japan
1 shared publication - Jun Kako
Graduate School of Medicine Mie University Tsu Japan
1 shared publication
Latest Publications
- Open Access
- 2 July 2026
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 34 (7)
Nonpharmacological interventions for preventing delirium in adult patients with cancer: a systematic review and meta-analysis
Purpose: To determine whether nonpharmacological interventions reduce delirium incidence in adult patients with cancer and to identify effective intervention strategies. Method: We conducted a systematic review and meta-analysis following PRISMA guidelines. PubMed, CENTRAL, CINAHL, and Ichushi-Web were searched through September 30, 2024, for randomized controlled trials (RCTs). Two authors independently extracted data, assessed the risk of bias using the Cochrane Risk of Bias 2 tool, and evaluated the certainty of evidence using the Grading of Recommendations Assessment, Development and Evaluation approach. The primary outcome was delirium incidence. A random-effects model was used for the meta-analysis. The study protocol was registered with UMIN-CTR (No. UMIN000051804; registered August 2, 2023). Results: Overall, 12 RCTs involving 2,747 patients were included. Interventions were categorized into multicomponent interventions, bright light therapy, rehabilitation, and anesthesia or oxygen management. The meta-analysis of five trials showed that multicomponent interventions significantly reduced delirium incidence (risk ratio [RR], 0.43; 95% confidence interval [CI], 0.31–0.60; moderate-certainty evidence), with benefit predominantly observed in postoperative settings. The evidence for bright light therapy was inconclusive (RR, 0.31; 95%CI, 0.07–1.31; very low-certainty evidence). Most of the included studies had concerns regarding the risk of bias, mainly due to a lack of blinding. Conclusion: Multicomponent nonpharmacological interventions may reduce delirium incidence in adult patients with cancer, particularly in postoperative or perioperative settings. However, the certainty of evidence is moderate, and the included studies vary in patient populations, intervention components, and healthcare settings. Evidence for standalone interventions and prevention strategies in palliative or end-of-life care remains limited and inconclusive.
- 2 July 2026
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 34 (7)
Open AccessNonpharmacological interventions for preventing delirium in adult patients with cancer: a systematic review and meta-analysis
Purpose: To determine whether nonpharmacological interventions reduce delirium incidence in adult patients with cancer and to identify effective intervention strategies. Method: We conducted a systematic review and meta-analysis following PRISMA guidelines. PubMed, CENTRAL, CINAHL, and Ichushi-Web were searched through September 30, 2024, for randomized controlled trials (RCTs). Two authors independently extracted data, assessed the risk of bias using the Cochrane Risk of Bias 2 tool, and evaluated the certainty of evidence using the Grading of Recommendations Assessment, Development and Evaluation approach. The primary outcome was delirium incidence. A random-effects model was used for the meta-analysis. The study protocol was registered with UMIN-CTR (No. UMIN000051804; registered August 2, 2023). Results: Overall, 12 RCTs involving 2,747 patients were included. Interventions were categorized into multicomponent interventions, bright light therapy, rehabilitation, and anesthesia or oxygen management. The meta-analysis of five trials showed that multicomponent interventions significantly reduced delirium incidence (risk ratio [RR], 0.43; 95% confidence interval [CI], 0.31–0.60; moderate-certainty evidence), with benefit predominantly observed in postoperative settings. The evidence for bright light therapy was inconclusive (RR, 0.31; 95%CI, 0.07–1.31; very low-certainty evidence). Most of the included studies had concerns regarding the risk of bias, mainly due to a lack of blinding. Conclusion: Multicomponent nonpharmacological interventions may reduce delirium incidence in adult patients with cancer, particularly in postoperative or perioperative settings. However, the certainty of evidence is moderate, and the included studies vary in patient populations, intervention components, and healthcare settings. Evidence for standalone interventions and prevention strategies in palliative or end-of-life care remains limited and inconclusive.
- 14 February 2025
- Published by Wiley in The Journal of Dermatology
- Vol. 52 (6)
Exacerbation of dipeptidyl peptidase‐ IV inhibitor‐associated bullous pemphigoid by the immune checkpoint inhibitors durvalumab and tremelimumab
- 14 February 2025
- Published by Wiley in The Journal of Dermatology
- Vol. 52 (6)
Exacerbation of dipeptidyl peptidase‐ IV inhibitor‐associated bullous pemphigoid by the immune checkpoint inhibitors durvalumab and tremelimumab